Do-Young Yoon
Overview
Explore the profile of Do-Young Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
2792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Lim C, Kim N, Kim H, Hong J, Yang Y, et al.
Sci Rep
. 2025 Jan;
15(1):1994.
PMID: 39814789
Exposure to particulate matter (PM) in the air harms human health. Most studies on particulate matter's (PM) effects have primarily focused on respiratory and cardiovascular diseases. Recently, IL-32θ, one of...
2.
Seo J, Lee Y, Jeon I, Yu J, Yoo J, Koo J, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519229
Interleukin-32γ (IL-32γ) has diverse functions in various malignancies. In this study, we investigated the role of IL-32γ in autophagy induction in liver cancer cells and delineated the underlying mechanisms. We...
3.
Kim J, Park H, Lim C, Jeon K, Kim S, Lee J, et al.
BMB Rep
. 2024 Oct;
57(11):490-496.
PMID: 39384176
Keratinocytes are susceptible to airborne particulate matter (PM) exposure, resulting in human skin barrier dysfunction. Therefore, it is important to find useful reagents to resolve skin damages caused by PM....
4.
Park H, Park J, Kim N, Kim H, Kim H, Son D, et al.
Immune Netw
. 2024 Jul;
24(3):e27.
PMID: 38974209
The tumor microenvironment (TME) is formed by several immune cells. Notably, tumor-associated macrophages (TAMs) are existed in the TME that induce angiogenesis, metastasis, and proliferation of cancer cells. Recently, a...
5.
Jeon K, Park H, Kim S, Kim N, Lee T, Oh D, et al.
Life Sci
. 2023 Nov;
336:122288.
PMID: 38007146
Aims: Protectin DX (PDX), a specialized pro-resolving mediator, is an important pharmaceutical compound with potential antioxidant and inflammation-resolving effects. However, the fundamental mechanism by which PDX's ameliorate chronic inflammatory diseases...
6.
Kim S, Jeon K, Park H, Kim J, Lim C, Yoon D
J Microbiol Biotechnol
. 2023 Nov;
34(3):506-515.
PMID: 37994116
Primary human dermal papilla cells (HDPCs) are often preferred in studies on hair growth and regeneration. However, primary HDPCs are limited by their reduced proliferative capacity, decreased hair induction potential,...
7.
Kim N, Park H, Park J, Kim U, Shin H, Lee H, et al.
BMB Rep
. 2023 Nov;
57(5):244-249.
PMID: 37964635
Many types of cancer are associated with excessive angiogenesis. Anti-angiogenic treatment is an effective strategy for treating solid cancers. This study aimed to demonstrate the inhibitory effects of (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl)...
8.
Kim N, Park H, Lee H, Hong J, Yoon D
J Microbiol Biotechnol
. 2023 Nov;
34(2):240-248.
PMID: 37942548
In cancer treatment, multi-target approach has paid attention to a reasonable strategy for the potential agents. We investigated whether (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol (MMPP) could exert an anticancer effect by dual-regulating...
9.
Park H, Park J, Kim N, Kim J, Pham T, Hong J, et al.
Biofactors
. 2023 Sep;
50(2):294-310.
PMID: 37658685
Breast cancer is a frequently diagnosed cancer and the leading cause of death among women worldwide. Tumor-associated macrophages stimulate cytokines and chemokines, which induce angiogenesis, metastasis, proliferation, and tumor-infiltrating immune...
10.
Park J, Park H, Kim S, Jeon K, Lim C, Hong J, et al.
Front Immunol
. 2023 May;
14:1160301.
PMID: 37228610
Interleukin-32 (IL-32), first reported in 2005, and its isoforms have been the subject of numerous studies investigating their functions in virus infection, cancer, and inflammation. IL-32θ, one of the IL-32...